Enhancing Calm in Arab Elderly With Dementia

Launched by MOSTAFA SHABAN · Jan 19, 2024

Keywords

ClinConnect Summary

This trial is checking whether a combined approach of Snoezelen multisensory therapy, calming aromatherapy, and the use of personal items can reduce agitation in Arab elderly people with dementia. It compares this integrated approach to usual care, in a randomized, parallel-group study at Cairo University in Giza, Egypt, aiming to enroll about 80 participants. The main question is whether agitation levels drop over about 4 weeks, measured with a standard agitation scale.

Eligible participants are adults with dementia, of Arab descent, usually in the 65–90 year age range (the study lists 60–90 in one section). They must show agitation and be able to participate in the sessions. Exclusions include very severe medical problems, advanced dementia, allergies to aromatherapy, or recent large changes in dementia medications. If you qualify, you’ll be randomly assigned to either the integrated Snoezelen-aromatherapy-personal item therapy or to standard care. Those in the intervention will have personalized sessions in a multisensory room, with calming scents and familiar personal items, guided by trained staff, and researchers will track agitation before and after about 4 weeks.

Gender

ALL

Eligibility criteria

• For the study \"Enhancing Calm in Arab Elderly with Dementia: Integrating Snoezelen Methods with Aromatherapy and Personal Items to Reduce Agitation\", here are the suggested Inclusion and Exclusion Criteria:
• Inclusion Criteria:
• • Age: Participants must be 65 years to 90 years
• • Diagnosis: Clinical diagnosis of dementia required.
• • Ethnicity: Must be of Arab descent.
• • Agitation Levels: Must show agitation signs based on a standardized scale.
• • Cognitive Function: Adequate cognitive function for study participation, verified by standard assessment.
• Exclusion Criteria:
• • Severe Medical Conditions: Individuals with severe medical conditions that could affect study participation or health.
• • Advanced Dementia: Patients with very advanced dementia stages, unable to engage in study activities.
• • Allergies: Known allergies to aromatherapy products used in the study.
• • Recent Medication Changes: Significant changes in dementia medication regimen before the study.